leucine and Severe Acute Respiratory Syndrome

leucine has been researched along with Severe Acute Respiratory Syndrome in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Dolgin, E	1
Arap, W; Kontoyiannis, DP; Pasqualini, R	1

Other Studies

2 other study(ies) available for leucine and Severe Acute Respiratory Syndrome

Article	Year
The race for antiviral drugs to beat COVID - and the next pandemic. Nature, 2021, Volume: 592, Issue:7854 Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Birds; Clinical Trials as Topic; Coronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cytidine; Drug Development; Drug Industry; Europe; Humans; Hydroxylamines; Indoles; Influenza, Human; Leucine; Orthomyxoviridae; Pandemics; Pyrrolidinones; Severe Acute Respiratory Syndrome; Strategic Stockpile; United States	2021
Aminopeptidase N inhibitors and SARS. Lancet (London, England), 2003, May-03, Volume: 361, Issue:9368 Topics: Antibodies, Monoclonal; Antiviral Agents; CD13 Antigens; Humans; Leucine; Severe Acute Respiratory Syndrome	2003

Article

Year

The race for antiviral drugs to beat COVID - and the next pandemic.

Nature, 2021, Volume: 592, Issue:7854

Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Birds; Clinical Trials as Topic; Coronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cytidine; Drug Development; Drug Industry; Europe; Humans; Hydroxylamines; Indoles; Influenza, Human; Leucine; Orthomyxoviridae; Pandemics; Pyrrolidinones; Severe Acute Respiratory Syndrome; Strategic Stockpile; United States

2021

Aminopeptidase N inhibitors and SARS.

Lancet (London, England), 2003, May-03, Volume: 361, Issue:9368

Topics: Antibodies, Monoclonal; Antiviral Agents; CD13 Antigens; Humans; Leucine; Severe Acute Respiratory Syndrome

2003